You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

 

ontario regulation 444/01

made under the

workplace safety and
insurance act, 1997

Made: October 22, 2001
Approved: November 28, 2001
Filed: November 30, 2001
Printed in The Ontario Gazette: December 15, 2001

Amending O. Reg. 175/98

(General)

1. Section 1 of Ontario Regulation 175/98 is amended by adding the following definition:

“manufacturing” includes making, preparing, altering, repairing, ornamenting, printing, finishing, packing, packaging, inspecting, testing, assembling the parts of and adapting for use or sale any article, commodity or raw material;

2. Items 11 and 12 of Schedule 2 to the Regulation are revoked.

3. Schedule 3 to the Regulation is revoked and the following substituted:

Schedule 3

OCCUPATIONAL DISEASES

Column 1

Column 2

Description of
Disease

Process

Poisoning and its Sequelae

1.

By arsenic

Any process involving exposure to or the use of arsenic, arsenic preparations or arsenic compounds

2.

By benzene

Any process involving exposure to or the use of benzene

3.

By beryllium

Any process involving exposure to or the use of beryllium, beryllium preparations or beryllium compounds

4.

By brass, nickel or zinc

Any melting or smelting process involving exposure to brass, nickel or zinc

5.

By cadmium

Any process involving exposure to or the use of cadmium, cadmium preparations or cadmium compounds

6.

By carbon dioxide

Any process involving exposure to carbon dioxide

7.

By carbon disulphide

Any process involving exposure to carbon disulphide

8.

By carbon monoxide

Any process involving exposure to carbon monoxide

9.

By chlorinated hydrocarbons

Any process in the manufacture of, or the use of, or involving exposure to chlorinated hydrocarbons

10.

By chromium

Any process involving exposure to or the use of chromium or chromium compounds

11.

By lead

Any process involving exposure to or the use of lead, lead preparations or lead compounds

12.

By mercury

Any process involving exposure to or the use of mercury, mercury preparations or mercury compounds

13.

By nitro- or amino- derivatives of benzene, phenol or their homologues

Any process involving manufacture, handling, use or exposure to nitro- or amino- derivatives of benzene, phenol or their homologues

14.

By oxides of nitrogen

Any process involving exposure to oxides of nitrogen

15.

By phosphorous

Any process involving exposure to or the use of phosphorus

Diseases from Biological Agents

16.

Anthrax

Handling of animals and animal parts, or any other process that results in exposure to a source of anthrax infection

17.

Tuberculosis

Any employment in a health care facility, a laboratory as defined in the Laboratory and Specimen Collection Centre Licensing Act or a reform institution, any employment in providing health care services or health care support services or any

 

 

other employment  in which there is a known risk of exposure to tuberculosis or to the tubercle bacillus

Diseases from Physical Agents

18.

Bursitis

Any process involving constant or prolonged friction to or pressure on the bursae

19.

Infected blisters

Any process involving friction to the skin that creates opportunity for infection

20.

Tenosynovitis

Any process involving continual or repetitive injury to tendons of the limbs

21.

Dysbarism: decompression sickness including caisson disease

Any process involving work in compressed or decompressed air

22.

Any disease due to exposure to X-rays, radium or other radioactive substances

 

Respiratory Diseases

23.

Asthma

Any process involving exposure to allergenic non-offset sprays in the printing industry

24.

Silicosis

Any process involving exposure to crystalline silica

25.

Pneumoconioses other than silicosis or asbestosis

Any process involving exposure to the relevant dust

Skin and Eye Diseases

26.

Allergic contact dermatitis

Any process involving exposure to a skin allergen

27.

Ulceration of the skin or cornea

Any process involving use, handling, or exposure to tar, pitch, bitumen, mineral oil or paraffin or any compound, product or residue of these substances

28.

Photo keratoconjunctivitis and photo retinitis

Any process involving prolonged or intense ultra-violet or infra-red exposure, including  gas or arc welding or use of  lasers

Cancer

29.

Epitheliomatous (skin) cancer

Any process involving use or handling of tar pitch, bitumen, mineral oil or paraffin or any compound, product or residue of these substances

30.

Primary cancer of the nasal cavities or of paranasal sinuses

Concentrating, smelting or refining in the nickel producing industry

 

4. (1) Subject to subsection (2), this Regulation comes into force on filing.

(2) Section 2 comes into force on January 1, 2002.

Workplace Safety and Insurance Board:

Glen Wright

Chair

Linda Angove

Secretary

Dated on October 22, 2001.